Edition 28 – Legal Obstacles to Biosimilar Market Entry

Legal Obstacles to Biosimilar Market Entry By Laura Karas, MD, MPH; Rachel Sachs, JD, MPH; Gerard Anderson, PhD Citation Karas L, Sachs R, Anderson G. Legal obstacles to biosimilar market entry. HPHR. 2021;28.  Legal Obstacles to Biosimilar Market Entry Abstract Improving the market availability and penetration of biosimilars, “follow-on” versions of biologic products, will require […]

Edition 25 – “The War on Drugs”: The Case of Bangladesh

Edition 25 - “The War on Drugs”: The Case of Bangladesh

“The War on Drugs”: The Case of Bangladesh By Nazrul Islam Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Islam N. War on drugs: the case of Bangladesh. Harvard Public Health Review. 2019;25 “The War on Drugs”: The Case of Bangladesh Despite decades of history of failure of the “war […]